"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead

Evaluation of patients with breast cancer according to histopathological types


Abstract

Introduction

It is known that invasive breast carcinoma consists ductal or lobular structures. However, currently, only about%10 are classified as specific types. Some of the histopathological subtypes have characteristic features in the terms of prognosis.

Material&Methods

We evaluated non metastatic invasive breast carcinoma patients according to age, menopausal status, histopathological subtype, hormone receptor status, stage and HER 2 status.

Results

A total of 77 patients were included in the study.  In the group of Invasive Ductal Carcinoma (IDC), 53 patients (%68.8) had a meanage of 55,2(range 35-83). 36 of them (%69) were post menopausal, 17  (%31) were premenopausal.. Staging of these patients were Stage I, II and III  10, 28 and 15 respectively. 43 patients (%81) had positive estrogen (ER) or progesterone receptor. Seventeen patients(%32)  had positive and 29 (%53) had negative HER 2 status

 

Nine patients(%11.6) with the meanage of 56,1 (range 34-76) were invasive lobuler carcinoma (ILC). Only three of them (%33,3) were premenopausal. Staging of these cases were Stage I, II and III 1, 5 and 3 respectively. All of ILC patients had ER or PR positive. Additionally three patients had positive and four patients were negative HER 2 status

There were seven cases (%9) with mixed type (lobular +ductal or any other of these two histologictype of tumor) of breast carcinoma. Only 2 patients were premenopausal. Meanage were 56,4 (36-71). All of them had positive with ER or PR while 3 cases were HER 2 status positive.

            There were eight patients  (%10,3) as specific types including two noroendocrin carcinoma,two intracyctic carsinoma, two meduller carcinoma, one papillary breast cancer and one occult breast carcinoma.

Discussion

We identified consistent rates with the literature on the analysis of histopathological subtypes. Furthermore, hormone receptor positivity was also consistent with the literature as ILC was higher than IDC.

 

Poster
non-peer-reviewed

Evaluation of patients with breast cancer according to histopathological types


Author Information

Orhan Üreyen Corresponding Author

General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

Enver İlhan

Department of General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

Abdullah Senlikci

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Ugu Gökcelli

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Demet Alay

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery


PDF Print Share
  • Author Information
    Orhan Üreyen Corresponding Author

    General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

    Enver İlhan

    Department of General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

    Abdullah Senlikci

    Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

    Ugu Gökcelli

    Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

    Demet Alay

    Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

    Poster Information
    Meeting

    First International Online BioMedical Conference September 09, 2015 - September 12, 2015

    Publication history

    Received by Cureus: August 30, 2015
    Published: September 09, 2015

    License

    This is an open access poster distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction

It is known that invasive breast carcinoma consists ductal or lobular structures. However, currently, only about%10 are classified as specific types. Some of the histopathological subtypes have characteristic features in the terms of prognosis.

Material&Methods

We evaluated non metastatic invasive breast carcinoma patients according to age, menopausal status, histopathological subtype, hormone receptor status, stage and HER 2 status.

Results

A total of 77 patients were included in the study.  In the group of Invasive Ductal Carcinoma (IDC), 53 patients (%68.8) had a meanage of 55,2(range 35-83). 36 of them (%69) were post menopausal, 17  (%31) were premenopausal.. Staging of these patients were Stage I, II and III  10, 28 and 15 respectively. 43 patients (%81) had positive estrogen (ER) or progesterone receptor. Seventeen patients(%32)  had positive and 29 (%53) had negative HER 2 status

 

Nine patients(%11.6) with the meanage of 56,1 (range 34-76) were invasive lobuler carcinoma (ILC). Only three of them (%33,3) were premenopausal. Staging of these cases were Stage I, II and III 1, 5 and 3 respectively. All of ILC patients had ER or PR positive. Additionally three patients had positive and four patients were negative HER 2 status

There were seven cases (%9) with mixed type (lobular +ductal or any other of these two histologictype of tumor) of breast carcinoma. Only 2 patients were premenopausal. Meanage were 56,4 (36-71). All of them had positive with ER or PR while 3 cases were HER 2 status positive.

            There were eight patients  (%10,3) as specific types including two noroendocrin carcinoma,two intracyctic carsinoma, two meduller carcinoma, one papillary breast cancer and one occult breast carcinoma.

Discussion

We identified consistent rates with the literature on the analysis of histopathological subtypes. Furthermore, hormone receptor positivity was also consistent with the literature as ILC was higher than IDC.

 

Orhan Üreyen

General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

For correspondence:
drureyen@yahoo.com

Enver İlhan

Department of General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

Abdullah Senlikci

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Ugu Gökcelli

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Demet Alay

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Orhan Üreyen

General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

For correspondence:
drureyen@yahoo.com

Enver İlhan

Department of General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

Abdullah Senlikci

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Ugu Gökcelli

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Demet Alay

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Orhan Üreyen

General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

For correspondence:
drureyen@yahoo.com

Enver İlhan

Department of General Surgery, Bozyaka Training and Research Hospital. Izmir/Turkey

Abdullah Senlikci

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Ugu Gökcelli

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Demet Alay

Bozyaka Training and Research Hospital. Izmir/Turkey, Department of General Surgery

Converted iobmc jpeg